ID   ACI-89
AC   CVCL_D717
SY   ACI-89-2
DR   cancercelllines; CVCL_D717
DR   Cosmic; 1622907
DR   Wikidata; Q54608411
RX   PubMed=19888321;
RX   PubMed=21882256;
CC   Sequence variation: Mutation; HGNC; HGNC:9302; PPP2R1A; Simple; p.Arg183Trp (c.547C>T); ClinVar=VCV000376505; Zygosity=Unspecified (PubMed=21882256).
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
RX   PubMed=19888321; DOI=10.1371/journal.pone.0007670; PMCID=PMC2765613;
RA   Wei B.-R., Hoover S.B., Ross M.M., Zhou W.-D., Meani F., Edwards J.B.,
RA   Spehalski E.I., Risinger J.I., Alvord W.G., Quinones O.A., Belluco C.,
RA   Martella L., Campagnutta E., Ravaggi A., Dai R.-M., Goldsmith P.K.,
RA   Woolard K.D., Pecorelli S., Liotta L.A., Petricoin E.F. 3rd,
RA   Simpson R.M.;
RT   "Serum S100A6 concentration predicts peritoneal tumor burden in mice
RT   with epithelial ovarian cancer and is associated with advanced stage
RT   in patients.";
RL   PLoS ONE 4:E7670-E7670(2009).
//
RX   PubMed=21882256; DOI=10.1002/mc.20850;
RA   Nagendra D.C., Burke J. 3rd, Maxwell G.L., Risinger J.I.;
RT   "PPP2R1A mutations are common in the serous type of endometrial
RT   cancer.";
RL   Mol. Carcinog. 51:826-831(2012).
//